PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability

Lan Yu(Southwestern Medical Center), Shanhu Li(Czech Academy of Sciences, Institute of Biotechnology)
Oncotarget
May 11, 2015
Cited by 17


Related Papers